|

Lepodisiran Clinical Trials

1 actively recruiting trial across 1 location

No change since June 2026

Also known as: LY3819469

Pipeline

Phase 3: 1

Top Sponsors

  • Eli Lilly and Company1

Indications

  • Heart Disease1
  • Lipoprotein(a)1
  • Cardiovascular Diseases1
  • Atherosclerosis1

La Jolla, California1 trial

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

UCSD - Altman Clinical and Translational Research Institute (ACTRI)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.